What Do Mick Jagger, Diabetes, Heart Disease, and Cancer Have in Common?

In this episode, Ms. Hammond talks about our aging society and how the industry needs to address its therapies to reflect the differences in age groups, including the old, and the very old.

Date Posted: 03/28/2013  Size: 9.6MB  Length: 00:20:52  

Thought Leader: Melissa Hammond MSN, GNP, Managing Director, Snowfish

Play podcast

Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.

Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development

Play podcast